FOLETTA MARK G 4

What Happened
Mark G. Foletta, a director of AMN Healthcare Services, sold a total of 3,681 shares of AMN common stock in open-market transactions on June 15, 2026. The sales consisted of 1,681 shares at a weighted-average price of $31.067 (total $52,224) and 2,000 shares at a weighted-average price of $31.069 (total $62,138), for aggregate proceeds of approximately $114,362. These were sales (not purchases), and both were executed under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: June 15, 2026 (Form 4 filed June 17, 2026) — appears to be filed within the normal two-business-day window.
• Sales: 1,681 shares (weighted avg $31.067; range $30.86–$31.22) and 2,000 shares (weighted avg $31.069; range $30.82–$31.22).
• Total shares sold: 3,681; total proceeds: ~$114,362.
• Ownership after transaction: Not specified in this Form 4; filing notes shares are held by The Foletta Family Trust DTD 1/30/2015, of which Mr. Foletta is trustee.
• Notable footnotes: Both sales were made pursuant to a Rule 10b5-1 trading plan adopted March 12, 2026 (F1, F4). The filing includes weighted-average prices and ranges and states the reporting person can provide a per-price breakdown on request (F2, F5).

Context

• Sales executed under a 10b5-1 plan are pre-planned and commonly used by insiders to systematically sell shares; they are generally viewed as less indicative of a change in the insider’s private view of the company than ad-hoc sales.
• This filing reports routine insider sell transactions (code S). There is no indication of option exercises, gifts, or tax-withholding in this report.